Table 1.
The correlation between the expression of DIAPH3 and the clinicopathological features in CRC
| Clinical classification | DIAPH3 expression | |||
|---|---|---|---|---|
| Total number | Low (number) | High (number) | p Value | |
| Gender | ||||
| Male | 92 | 37 | 55 | 0.436 |
| Female | 84 | 29 | 55 | |
| Age (years) | ||||
| ≥ 65 | 91 | 34 | 57 | 0.969 |
| < 65 | 85 | 32 | 53 | |
| T stage | ||||
| T1/2 | 19 | 9 | 10 | 0.347 |
| T3/4 | 157 | 57 | 100 | |
| N stage | ||||
| N0 | 97 | 43 | 54 | 0.038 |
| N1/2 | 79 | 23 | 56 | |
| M stage | ||||
| M0 | 147 | 60 | 87 | 0.041 |
| M1 | 29 | 6 | 23 | |
| AJCC stage | ||||
| AJCC1/2 | 94 | 45 | 49 | 0.002 |
| AJCC3/4 | 82 | 21 | 61 | |
AJCC American Joint Committee on Cancer, N lymph node, M metastasis, T tumor